Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7118 | 1327 | 24.2 | 57% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
618 | 13204 | HAEMOPHILIA//HAEMOPHILIA A//VON WILLEBRAND DISEASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ASSAY DISCREPANCIES | Author keyword | 8 | 100% | 0% | 5 |
2 | HEMOPHILIA TREATMENT | Author keyword | 4 | 75% | 0% | 3 |
3 | FACTOR VIII CONCENTRATE | Author keyword | 4 | 31% | 1% | 11 |
4 | MONONINE | Author keyword | 3 | 100% | 0% | 3 |
5 | FACTOR IX CONCENTRATE | Author keyword | 3 | 42% | 0% | 5 |
6 | CONGENITAL BLEEDING DISORDER | Author keyword | 2 | 38% | 0% | 5 |
7 | ACTIVATED FACTORS | Author keyword | 2 | 67% | 0% | 2 |
8 | NATIONAL BIOLOGICAL STANDARD | Author keyword | 2 | 67% | 0% | 2 |
9 | S D PLASMA | Author keyword | 2 | 67% | 0% | 2 |
10 | THROMBOSIS HAEMOSTASIS RHEOL | Address | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ASSAY DISCREPANCIES | 8 | 100% | 0% | 5 | Search ASSAY+DISCREPANCIES | Search ASSAY+DISCREPANCIES |
2 | HEMOPHILIA TREATMENT | 4 | 75% | 0% | 3 | Search HEMOPHILIA+TREATMENT | Search HEMOPHILIA+TREATMENT |
3 | FACTOR VIII CONCENTRATE | 4 | 31% | 1% | 11 | Search FACTOR+VIII+CONCENTRATE | Search FACTOR+VIII+CONCENTRATE |
4 | MONONINE | 3 | 100% | 0% | 3 | Search MONONINE | Search MONONINE |
5 | FACTOR IX CONCENTRATE | 3 | 42% | 0% | 5 | Search FACTOR+IX+CONCENTRATE | Search FACTOR+IX+CONCENTRATE |
6 | CONGENITAL BLEEDING DISORDER | 2 | 38% | 0% | 5 | Search CONGENITAL+BLEEDING+DISORDER | Search CONGENITAL+BLEEDING+DISORDER |
7 | ACTIVATED FACTORS | 2 | 67% | 0% | 2 | Search ACTIVATED+FACTORS | Search ACTIVATED+FACTORS |
8 | NATIONAL BIOLOGICAL STANDARD | 2 | 67% | 0% | 2 | Search NATIONAL+BIOLOGICAL+STANDARD | Search NATIONAL+BIOLOGICAL+STANDARD |
9 | S D PLASMA | 2 | 67% | 0% | 2 | Search S+D+PLASMA | Search S+D+PLASMA |
10 | FACTOR IX CONCENTRATES | 2 | 50% | 0% | 3 | Search FACTOR+IX+CONCENTRATES | Search FACTOR+IX+CONCENTRATES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PURIFIED FACTOR IX | 38 | 76% | 2% | 26 |
2 | MODEL INDEPENDENT METHODS | 31 | 73% | 2% | 24 |
3 | PURIFIED FACTOR VIII | 27 | 70% | 2% | 23 |
4 | FACTOR VIII CONCENTRATE | 27 | 30% | 6% | 77 |
5 | INVIVO THROMBOGENICITY | 23 | 76% | 1% | 16 |
6 | HUMAN MONOCYTE FUNCTIONS | 19 | 80% | 1% | 12 |
7 | INFECTED HEMOPHILIACS | 18 | 59% | 2% | 20 |
8 | FACTOR IX CONCENTRATE | 15 | 41% | 2% | 28 |
9 | HEMOPHILIC PATIENTS | 12 | 39% | 2% | 24 |
10 | 2 STAGE ASSAY | 12 | 86% | 0% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The pharmacokinetics of factor VIII and factor IX: Methodology, pitfalls and applications | 1997 | 33 | 47 | 87% |
Monitoring of modified factor VIII and IX products | 2014 | 2 | 27 | 67% |
Pharmacokinetics of coagulation factors clinical relevance for patients with haemophilia | 2001 | 66 | 114 | 46% |
CLINICAL-EVALUATION OF VIRAL SAFETY OF COAGULATION FACTOR-VIII AND FACTOR-IX CONCENTRATES | 1993 | 68 | 24 | 92% |
Treatment of chronic hepatitis C in patients with haemophilia: a review of the literature | 2006 | 8 | 48 | 65% |
Treatment of hepatitis C in hemophiliacs | 2006 | 5 | 53 | 64% |
RECENT EVOLUTION OF CLOTTING FACTOR CONCENTRATES FOR HEMOPHILIA-A AND HEMOPHILIA-B | 1993 | 42 | 57 | 68% |
Treatment of haemophilia patients in East Germany prior to and after reunification in 1990 | 2014 | 0 | 5 | 80% |
FACTOR CONCENTRATES FOR TREATMENT OF HEMOPHILIA - WHICH ONE TO CHOOSE | 1989 | 78 | 25 | 48% |
PHARMACOKINETICS OF FACTOR-VIII IN HUMANS - OBTAINING CLINICALLY RELEVANT DATA FROM COMPARATIVE-STUDIES | 1992 | 29 | 20 | 80% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | THROMBOSIS HAEMOSTASIS RHEOL | 2 | 67% | 0.2% | 2 |
2 | HAEMOSTASIS SECT | 2 | 22% | 0.5% | 7 |
3 | ASESORIA CIENT | 1 | 100% | 0.2% | 2 |
4 | W MIDLANDS ADULT COMPREHENS CARE HAEMOPHILIA | 1 | 40% | 0.2% | 2 |
5 | CORNELL MED RADIOL | 1 | 50% | 0.1% | 1 |
6 | CREVELDKLINIEK | 1 | 50% | 0.1% | 1 |
7 | ESTRUCT SUPERFICIE VIRUS ENVELOPADOS INTERF | 1 | 50% | 0.1% | 1 |
8 | HAEMOPHILIA HAEMOSTASIS | 1 | 50% | 0.1% | 1 |
9 | LIVER TRANSPLANTAT HEPATOBILIARY | 1 | 50% | 0.1% | 1 |
10 | LOCAL HLTH AUTHOR MILAN | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000176886 | FACTOR VIII//FACTOR VIII INHIBITOR//ACQUIRED HEMOPHILIA |
2 | 0.0000142033 | HAEMOPHILIA//VAN CREVELDKLIN//HEMOPHILIA |
3 | 0.0000107644 | AMOTOSALEN//PATHOGEN INACTIVATION//SOLVENT DETERGENT |
4 | 0.0000081979 | PROTHROMBIN COMPLEX CONCENTRATE//PROTHROMBIN COMPLEX CONCENTRATES//ANTICOAGULATION REVERSAL |
5 | 0.0000081534 | ELECTROLYTES IN BLOOD SERUM//GERIATRIC GYNECOLOGY//DESCENSUS |
6 | 0.0000076371 | DESMOPRESSIN//DDAVP//PHARMACOLOGY DESMOPRESSIN |
7 | 0.0000069145 | AIDS RESEARCH//IMMUNE COMPLEX DISSOCIATION//ANNALES DE L INSTITUT PASTEUR-VIROLOGY |
8 | 0.0000064525 | RIBA//ANTI HCV//NON A NON B HEPATITIS |
9 | 0.0000051989 | VON WILLEBRAND DISEASE//VON WILLEBRAND FACTOR//VWD |
10 | 0.0000044768 | RFVIIA//RECOMBINANT ACTIVATED FACTOR VII//RECOMBINANT FACTOR VIIA |